Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma
- 1 October 2003
- journal article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 29 (8), 662-664
- https://doi.org/10.1016/s0748-7983(03)00147-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanomaEuropean Journal of Surgical Oncology, 2002
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- FDG–PET sensitivity for melanoma lymph node metastases is dependent on tumor volumeJournal of Surgical Oncology, 2001
- The Definition of a Sentinel NodeAnnals of Surgical Oncology, 2001
- Comparison of Positron Emission Tomography Scanning and Sentinel Node Biopsy in the Detection of Micrometastases of Primary Cutaneous Malignant MelanomaJournal of Clinical Oncology, 2001
- Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage MelanomaAnnals of Surgery, 1999
- Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma PatientsJournal of Clinical Oncology, 1999
- Sentinel lymph node detection and imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Primary staging and follow-up of high risk melanoma patients with whole-body18F-fluorodeoxyglucose positron emission tomographyCancer, 1998
- Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.Journal of Clinical Oncology, 1998